Moleculin announced the exercise of warrants that will generate $8.3 million in gross proceeds. This financing method enables the biotech company to secure capital from previous investors while minimizing immediate share dilution. Moleculin continues to focus on its lead asset, annamycin, in its oncology clinical programs.
Cosmos Health has highlighted that its real estate assets have an approximate fair market value of $15 million, which exceeds the company’s current market capitalization. In light of ongoing valuation pressures in the biotech and […]
Pudgy Penguins has launched Pudgy World, a free-to-play browser-based game that invites players to explore 12 unique towns in The Berg while helping the character Pengu find Polly through various mini-games. This launch aligns with […]
During the ETH ChiangMai togETHer Tuesday event on January 27, Ethereum founder Vitalik Buterin asserted that the blockchain trilemma—balancing scalability, consensus, and decentralization—is an engineering challenge rather than an insurmountable mathematical theorem. He highlighted technological […]